Cargando…

Long Term Metabolic and Inflammatory Effects of Second-Generation Antipsychotics: A Study in Mentally Disordered Offenders

Mentally disordered offenders provided with forensic psychiatric care are often treated with second generation antipsychotic (SGA) medication and experience metabolic and inflammatory side effects. Aim: In this paper, we monitored the three-year fluctuation of selected anthropometric, biochemical, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vassilopoulou, Emilia, Efthymiou, Dimitris, Papatriantafyllou, Evangelia, Markopoulou, Maria, Sakellariou, Efthymia-Maria, Popescu, Alina Codruta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617708/ https://www.ncbi.nlm.nih.gov/pubmed/34834541 http://dx.doi.org/10.3390/jpm11111189

Ejemplares similares

The Effects of Use of Long-Term Second-Generation Antipsychotics on Liver and Kidney Function: A Prospective Study
por: Papatriantafyllou, Evangelia, et al.
Publicado: (2022)

Sleep Deprivation: Effects on Weight Loss and Weight Loss Maintenance
por: Papatriantafyllou, Evangelia, et al.
Publicado: (2022)

Gait Alterations in the Prediction of Metabolic Syndrome in Patients With Schizophrenia: A Pilot Study With PODOSmart ® Insoles
por: Efthymiou, Dimitris, et al.
Publicado: (2022)

Food Allergy Management Competence in Greek Schools
por: Feketea, Gavriela, et al.
Publicado: (2023)

Halting the Metabolic Complications of Antipsychotic Medication in Patients with a First Episode of Psychosis: How Far Can We Go with the Mediterranean Diet? A Pilot Study
por: Ntalkitsi, Savina, et al.
Publicado: (2022)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
por: Vassilopoulou, Emilia, et al.
Publicado: (2022)

Perceived ideal body weight exacerbates bulimia and dieting in Bodybuilding Athletes
por: Efthymiou, Dimitris, et al.
Publicado: (2021)

The Mentally Abnormal Offender
por: Gallwey, P. L. G.
Publicado: (1968)

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects
por: Divac, Nevena, et al.
Publicado: (2014)

Diabetes Prevalence and Risk Factors in Patients With Chronic Mental Illness on Second-Generation Antipsychotics
por: Sahay, Priya, et al.
Publicado: (2021)

Alliance with the School Personnel Is Crucial for the Management of Food Allergy and Anaphylaxis in School Children
por: Efthymiou, Dimitris, et al.
Publicado: (2021)

Gait Analysis, Metabolic Parameters and Adherence to the Mediterranean Diet in Patients with Type 2 Diabetes Mellitus Compared with Healthy Controls: A Pilot Study
por: Efthymiou, Dimitris, et al.
Publicado: (2023)

Mental Illness and Juvenile Offenders
por: Underwood, Lee A., et al.
Publicado: (2016)

The Mentally Abnormal Offender and the Law
por: Gallwey, P. L. G.
Publicado: (1969)

The Law and the Mentally Abnormal Offender
por: Rollin, Henry R.
Publicado: (1965)

Arterial Stiffness in Patients Taking Second-generation Antipsychotics
por: Fındıklı, Ebru, et al.
Publicado: (2016)

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020)

Second-generation antipsychotic use during pregnancy and risk of congenital malformations
por: Ellfolk, Maria, et al.
Publicado: (2021)

Adherence to Antipsychotic Medication and Criminal Recidivism in a Canadian Provincial Offender Population
por: Rezansoff, Stefanie N, et al.
Publicado: (2017)

First-generation vs second-generation antipsychotic drugs: The ongoing saga
por: Gupta, Sumeet
Publicado: (2010)

Relapse Prevention in Schizophrenia: A Systematic Review and Meta-Analysis of Second-Generation Antipsychotics versus First-Generation Antipsychotics
por: Kishimoto, Taishiro, et al.
Publicado: (2011)

Mental health assessment of rape offenders
por: Sarkar, Jaydip
Publicado: (2013)

Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008)

Inhibition of mouse brown adipocyte differentiation by second-generation antipsychotics
por: Oh, Jee-Eun, et al.
Publicado: (2012)

Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)

Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update
por: Wang, Sheng-Min, et al.
Publicado: (2016)

Overcoming barriers to monitoring patients taking second-generation antipsychotics
por: Peña, Anita, et al.
Publicado: (2018)

Updating the Comparative Evidence on Second‐Generation Antipsychotic Use With Schizophrenia
por: McDonagh, Marian S., et al.
Publicado: (2020)

Combination treatment with second generation antipsychotics other than clozapine
por: Schmidt-Kraepelin, C.
Publicado: (2021)

Risk of Breast Cancer in Association with the Use of Second-generation Antipsychotics
por: Joo, Sung Woo, et al.
Publicado: (2022)

Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis
por: Ramachandran, Sujith, et al.
Publicado: (2016)

Gender and race disparities in weight gain among offenders prescribed antidepressant and antipsychotic medications
por: Gates, Madison L., et al.
Publicado: (2016)

Serving mentally ill offenders : challenges and opportunities for mental health professionals /
Publicado: (2002)

Student Disaffection: The Contribution of Greek In-service Kindergarten Teachers in Engaging Each Preschooler in Learning
por: Sakellariou, Maria, et al.
Publicado: (2020)

Childhood traumatic experiences and mental health problems in sexually offending and non-sexually offending juveniles
por: Boonmann, Cyril, et al.
Publicado: (2016)

Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2021)

Teetering on the Edge: Second-Degree Atrioventricular Block Following Long-Acting Second-Generation Antipsychotic
por: Harrisingh, Kamahl, et al.
Publicado: (2023)

Effectiveness of second generation antipsychotics: A systematic review of randomized trials
por: Johnsen, Erik, et al.
Publicado: (2008)

Blood lactate levels in patients receiving first- or second- generation antipsychotics
por: Glavina, Trpimir, et al.
Publicado: (2011)

Second-Generation Antipsychotic Discontinuation in First Episode Psychosis: An Updated Review
por: Miller, Brian J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d2vfnqa2vo4lkb32eld71sham5